COMMITTEE

ADVISORY BOARD
Prof. Dr. dr. Aryati, SpPK (K)
Dr. dr. Sri Hartini, SpPK(K), MARS
Dr. dr. Teguh Triyono, M.Kes, SpPK(K)
dr. Marina Ludong, SpPK
Dr. dr. Agus S. Kosasih, SpPK(K), MARS

CHAIRMAN
dr. Dewi Yennita Sari, SpPK

CO-CHAIRMAN
dr. Firsty Florentia, SpPK

sECRETARIES
QUALITY
FUNDING COMMITTEE
dr. Yusra, SpPK, PhD Dr. dr. Agus S. Kosasih, SpPK(K),
dr. Lilik Indrawati, SpPK MARS
dr. Ro Shinta Solin, SpPK

dr. Tri Kusuma Widiasih, SpPK
dr. Yona Minanda, SpPK
MANAGEMENT
dr. Marina Ludong, SpPK
Dr. Nuri Dyah I, SpPK(K)
Dr.dr. Purwanto AP, SpPK(K)
Dr.dr. Anggraini Iriani, SpPK

TREASURES
dr. Ni Sayu Dewi, SpPK (K), Mkes
DOCUMENTATION COMMITTEE
dr. Dean Hadimulya, SpPK
IN RAPID
DIAGNOSTIC
dr. Christine Sugiarto, SpPK
dr. Suganda, SpPK
dr. Ryan B Ristandi, SpPK, MMRS
SCIENTIFIC COMMITTEE
TESTING
Dr. dr. Lyana Setiawan, SpPK (K)
dr. Lidya Utami, SpPK(K)
dr. Tjan Sian Hwa, SpPK, MSc
dr. Bettia Bermawi,SpPK

PROCEEDING COMMITTEE ACCOMODATION COMMITTEE

Jakarta, June 18 - 19th 2021
dr. Astuti Giantini, SpPK, MPH dr. Weny Rinawati, SpPK(K), MARS
dr. MI Dyah, SpPK dr. Uleng Bahrun, SpPK(K), PhD
dr. Muhammad R. Fuadi, SpPK(K) dr. Veronica Petri, SpPK
dr.
dr.
dr.
Hery Priyanto, SpPK
Hubertus H. Hayuanta, SpPK
Agus Setiawan, SpPK
REGISTRATION
dr. Cut Nur C. Alamanda, SpPK, Mkes
dr. Thyrza L Dharmadi, SpPK
Dr. dr. Lyana Setiawan, SpPK (k) UNTIL JUNE, 15TH 20021 IDR 250.000
dr. Lidya Utami, SpPK(K)
dr. Tjan Sian Hwa, SpPK, MSc
dr. Bettia Bermawi,SpPK
Transfer should be made to
Bank Mandiri
117-00-0645897-0
Badan Khusus PKEL Seminar

Contact person :
Opie : +62 812 8831 746
Aini : +62 838 0792 1115
 FRIDAY TOPICS
Road map to Quality in Clinical
Laboratory service
drg. Farichah Hanum, M.Kes
Director of Health Service Quality & Accreditation of
The Indonesian Ministry of Health
Updates of Clinical Pathologist role in
quality assurance
of rapid diagnostic test and management
Prof. Dr. dr. Aryati, MS SpPK(K)
RAPID DIAGNOSTIC TEST MANAGEMENT
RDT: in Quality we trust
Prof Tony Badric
Assessment the need of POCT service and
the quality requirement
dr. Nuri Dyah I, SpPK(K)
Managing POCT in hospital
Dr. Ira Puspitawati, SpPK
THE QUEST FOR QUALITY OF RDT IN CLINICAL
SETTING
Providing high quality assay for Diabetes
diagnosis and monitoring with RDT
dr. Maria I. Diah Pramudianti, MSc.,SpPK(K)
ARDT role for emergency and critical role :
delicate balance between speed and
quality
Dr. dr. Hartono Kahar, SpPK (K)
QUALITY AS PRIORITY IN APPLYING RDT FOR
COVID-19 DIAGNOSIS AND TRACING
Principles and application of high quality
antigen and antibody RDT for COVID-19
Dr Uleng Bahrun, SpPK (K), PhD
RDT of molecular assay in COVID-19 : how far
we can rely
dr. Basti Andrioko, SpPK (K)
FOREWORD SATURDAY TOPICS
Rapid diagnostic tests (RDTs) can speed the
etiologic diagnosis of infections in several Role of EQAS in pandemic
scenarios (e.g., sepsis, respiratory tract Dr. Tjan Sian Hwa, SpPK
infections, and meningitis), and can be used as
point of care testing in emergency or critical BEST PRACTICE IN QUALITY CONTROL
care. Interpretation of currently available RDTs Sigma strong for better result in Chemistry
is not always straightforward, and therefore, analyzer
they cannot yet replace conventional tests. TBA
Institutional priorities, integration with Experience in using Sigma Strong analyzer
laboratory workflow, and cost are issues that TBA
have to be considered when selecting RDTs to Six sigma new rules
implement locally.
Sten Westgard
Quality assurance (QA) is essential for EQAS CASE
programs to monitor and improve the quality of CLINICAL CHEMISTRY CLINICAL CHEMISTRY TEAM
diagnostic testing. QA is all of the systematic
activities that demonstrate confidence that a URINALISYS URINALYSIS TEAM
product or service fulfills its requirements.
International Organization for Standardization HEMATOLOGY HEMATOLOGY TEAM
provide program for diagnostics is designed to
guarantee that the final diagnostic results
reported by a laboratory or testing program are HEMOSTASIS HEMOSTASIS TEAM
as accurate as possible.
MICROBIOLOGY MICROBIOLOGY TEAM
Implementing diagnostic testing with rapid
tests in parallel with a QA program reinforces
the validity of the test results, builds capacity
to use rapid tests for surveillance and research,
and aligns with global guidance and best
practices for the post-market surveillance of
new diagnostic tools